Gastrointestinal Mechanisms Underlying the Cardiovascular Effect of Metformin

Metformin, the most widely prescribed drug therapy for type 2 diabetes, has pleiotropic benefits, in addition to its capacity to lower elevated blood glucose levels, including mitigation of cardiovascular risk. The mechanisms underlying the latter remain unclear. Mechanistic studies have, hitherto,...

Full description

Bibliographic Details
Published in:	Pharmaceuticals
Main Authors:	Malcolm J. Borg, Christopher K. Rayner, Karen L. Jones, Michael Horowitz, Cong Xie, Tongzhi Wu
Format:	Article
Language:	English
Published:	MDPI AG 2020-11-01
Subjects:	metformin cardiovascular gastrointestinal mechanisms bile acids gut microbiota
Online Access:	https://www.mdpi.com/1424-8247/13/11/410

Similar Items

Understanding the action mechanisms of metformin in the gastrointestinal tract
by: Meihui Cheng, et al.
Published: (2024-03-01)

Advances in the mechanism of metformin with wide-ranging effects on regulation of the intestinal microbiota
by: Yue Wang, et al.
Published: (2024-05-01)

Gut microbiota is correlated with gastrointestinal adverse events of metformin in patients with type 2 diabetes
by: Yuxin Huang, et al.
Published: (2022-11-01)

Effect of metformin and metformin/linagliptin on gut microbiota in patients with prediabetes
by: Yoscelina Estrella Martínez-López, et al.
Published: (2024-04-01)

Metformin as a Multifaceted Therapeutic Agent for Gastrointestinal Diseases: Mechanisms, Clinical Efficacy, and Future Directions
by: Sayedeh Azimeh Hosseini, et al.
Published: (2026-06-01)

Zuojinwan ameliorates depressive-like behavior and gastrointestinal dysfunction in mice by modulating the FXR-bile acid-gut microbiota pathway
by: Dan Qiao, et al.
Published: (2025-06-01)

Cardiovascular Effects of Metformin
by: B. T. Kurmanbekova, et al.
Published: (2022-03-01)

Severity of gastrointestinal side effects of metformin tablet compared to metformin capsule in type 2 diabetes mellitus patients
by: Mansour Siavash, et al.
Published: (2017-01-01)

Effects of metformin on the gut microbiota: A systematic review
by: Pavlo Petakh, et al.
Published: (2023-11-01)

Chemopreventive Effect of Metformin on Gastric Cancer Development
by: Ka Shing Cheung, et al.
Published: (2022-03-01)

Gut microbiota-derived gamma-aminobutyric acid from metformin treatment reduces hepatic ischemia/reperfusion injury through inhibiting ferroptosis
by: Fangyan Wang, et al.
Published: (2024-03-01)

Enteroendocrine Hormone Secretion and Metabolic Control: Importance of the Region of the Gut Stimulation
by: Cong Xie, et al.
Published: (2020-08-01)

Impact of stool transplantation and metformin on polyp reduction and inflammation in an APC Min mouse model
by: Yeon Ji Kim, et al.
Published: (2025-07-01)

Effects of Metformin on the Gut Microbiota in Obesity and Type 2 Diabetes Mellitus
by: Zhang Q, et al.
Published: (2020-12-01)

Potential benefits of metformin and pioglitazone combination therapy via gut microbiota and metabolites in high-fat diet-fed mice
by: Dongmei Wang, et al.
Published: (2022-10-01)

Cardiovascular effects of metformin: focus on adipose tissue metabolism
by: Olga V. Gruzdeva, et al.
Published: (2022-09-01)

Metformin Mitigates Sepsis-Related Neuroinflammation via Modulating Gut Microbiota and Metabolites
by: Huayan Zhao, et al.
Published: (2022-04-01)

Effect of Metformin on Antipsychotic-Induced Metabolic Dysfunction: The Potential Role of Gut-Brain Axis
by: Chao Luo, et al.
Published: (2019-04-01)

Lutein augments the hypoglycemic effect of metformin through the gut microbiota-imidazole propionate axis in type 2 diabetic model mice
by: Kai Liu, et al.
Published: (2025-08-01)

Are There Differences in Gut Microbiome in Patients with Type 2 Diabetes Treated by Metformin or Metformin and Insulin?
by: Dzięgielewska-Gęsiak S, et al.
Published: (2022-11-01)

Unveiling the potential pleiotropic effects of metformin in treating COVID-19: a comprehensive review
by: Pavlo Petakh, et al.
Published: (2023-10-01)

Combination of Oligofructose and Metformin Alters the Gut Microbiota and Improves Metabolic Profiles, Contributing to the Potentiated Therapeutic Effects on Diet-Induced Obese Animals
by: Qingzhong Li, et al.
Published: (2020-02-01)

The influence of metformin and empagliflozin administration on gut microbiota in individuals with type 2 diabetes mellitus and hypothyroidism
by: K.A. Moskva, et al.
Published: (2024-06-01)

Flos Lonicera Combined with Metformin Ameliorates Hepatosteatosis and Glucose Intolerance in Association with Gut Microbiota Modulation
by: Na R. Shin, et al.
Published: (2017-11-01)

Longitudinal variations in the gastrointestinal microbiome of the white shrimp, Litopenaeus vannamei
by: Estefanía Garibay-Valdez, et al.
Published: (2021-08-01)

Metformin Therapy Changes Gut Microbiota Alpha-Diversity in COVID-19 Patients with Type 2 Diabetes: The Role of SARS-CoV-2 Variants and Antibiotic Treatment
by: Pavlo Petakh, et al.
Published: (2023-06-01)

Microbial succinate promotes the response to metformin by upregulating secretory immunoglobulin a in intestinal immunity
by: Ying Zhang, et al.
Published: (2025-12-01)

The emerging role of the microbial-gastrointestinal-neural axis
by: Peter G. McLean, et al.
Published: (2009-10-01)

Metformin-associated gut microbiota remodeling correlates with reinvigorated splenic immunity in aged mice: microbiome-immune crosstalk via the gut-spleen axis
by: Shu-Qin Ding, et al.
Published: (2025-09-01)

Risk of antidepressant initiation among users of cardiovascular agents and metformin.
by: Ivana Bojanić, et al.
Published: (2023-04-01)

Editorial: The role of gut microbiota in animal gastrointestinal diseases
by: Aoyun Li, et al.
Published: (2025-01-01)

Pathogenic role of the gut microbiota in gastrointestinal diseases
by: Hiroko Nagao-Kitamoto, et al.
Published: (2016-04-01)

Gut microbiota-derived glutathione from metformin treatment alleviates intestinal ferroptosis induced by ischemia/reperfusion
by: Fangyan Wang, et al.
Published: (2025-05-01)

Metformin-Associated Gastrointestinal Adverse Events Are Reduced by Probiotics: A Meta-Analysis
by: Izabela Szymczak-Pajor, et al.
Published: (2024-07-01)

The effects of prebiotics on gastrointestinal side effects of metformin in youth: A pilot randomized control trial in youth-onset type 2 diabetes
by: Sydney A. Dixon, et al.
Published: (2023-02-01)

Naringenin Promotes Gastrointestinal Motility in Mice by Impacting the SCF/c-Kit Pathway and Gut Microbiota
by: Lei Wu, et al.
Published: (2024-08-01)

Sex differences in the skeletal muscle response to metformin treatment and the possible association with gut-muscle axis in rats
by: Lin Song, et al.
Published: (2025-09-01)

Is there a relationship between metformin-related gastrointestinal symptoms and vitamin B12 deficiency in patients with type 2 diabetes mellitus?
by: Fatih Eskin, et al.
Published: (2023-03-01)

Metformin beyond Glycemic Control: New Mechanistic Insights and Expanding Therapeutic Horizons
by: Eugene Han, et al.
Published: (2026-05-01)

Effects of isolation and confinement on gastrointestinal microbiota–a systematic review
by: Bea Klos, et al.
Published: (2023-07-01)